Company
Marianaoncology
Precision cancer therapies for a better treatment journey
Also known as Mariana Oncology
- Status
- Acquiredas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2021
- marianaoncology.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Mariana Oncology, a Novartis company, we believe we are on the cusp of a paradigm shift in cancer care: precision radioligand therapies designed to optimize efficacy while allowing patients to live better during their treatment journey.
Funding snapshot
- Total raised
- $175MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $175M2023-09-07
Funding rounds
- Series B
- $175M2023-09-07, Company stated
About the company
- Status notes
- Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Exit
- Acquisition
- 2024-05-02
Loading relationship preview